Actilyse 10 mg powder and solvent for solution for injection and infusion

DRUG2 trials

Sponsors

King's College London, King's College Hospital NHS Foundation Trust, Rigshospitalet

Conditions

Exudative age-related macular degenerationPulmonary embolism

Phase 3

Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative age-Related macular degeneration (TIGER): a phase 3, pan-European, two-group, active-control, observer-masked, superiority, randomised controlled surgical trial.

RecruitingCTIS2023-504751-28-00

King's College London, King's College Hospital NHS Foundation TrustExudative age-related macular degeneration

Start: 2024-09-24Target: 61Updated: 2025-12-16

Phase 4

PERCUTANEOUS EMBOLECTOMY, ULTRASOUND ASSISTED LOW DOSE THROMBOLYSIS OR HEPARIN FOR INTERMEDIATE HIGH RISK PULMONARY EMBOLISM (STRATIFY II)

Not yet recruitingCTIS2024-515712-45-00

RigshospitaletPulmonary embolism

Target: 210Updated: 2024-10-18